The compound did not affect fasting glucose, insulin, HbA1c, IGF-1, cortisol, thyroid hormones, or liver enzymes (Thompson et al., 2004)
It also regulates blood pressure and cholesterol levels
Two six-month pediatric studies were conducted to evaluate the long-term safety of divalproex sodium ER for the indication of mania (292 patients aged 10 to 17 years)
But the most important metrics for employers are: Clinical outcomes % weight loss at 3, 6, 12 months Improvements in blood pressure, HbA1c, cholesterol (where available) Medication usage trends Average GLP-1 dose per member Time on medication Escalation and tapering rates Behavior change engagement Weekly coaching session attendance Improvements in sleep, nutrition, movement, stress Financial impact Changes in obesity-related claims (e.g
Antioxidant capacity of follicular fluid from patients undergoing in vitro fertilization